MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    D. Floden, C. Matias, C. Wathen, G. Ozinga, O. Hogue, A. Machado (Cleveland, OH, USA)

    Objective: To determine whether the precise location of stimulation affects cognitive performance and mood. Background: Deep brain stimulation of the subthalamic nucleus effectively treats the…
  • 2017 International Congress

    Comparison of lead localization in postoperative CT versus MRI

    R. Nickl, M. Reich, P. Fricke, F. Steigerwald, F. Lange, R.-I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)

    Objective: Evaluation of lead position accuracy may be accomplished by postoperative CT or MRI. Image distortion induced by the lead contacts in MRI question the…
  • 2017 International Congress

    Expectations and Perceived Outcomes Following DBS for PD: A Case Series

    D. Coughlin, M. Hernandez-Con, M. Pavon, M. Spindler, L. Chahine (Philadelphia, PA, USA)

    Objective: To examine effect of preoperative expectations on postoperative satisfaction in individuals with PD treated with DBS Background: While clinical trials of DBS in PD…
  • 2017 International Congress

    Transcranial sonography in the prognosis of drug-induced parkinsonism

    Y.-S. Oh, D.-Y. Kwon (Seoul, Republic of Korea)

    Objective: We investigated the substantia nigra (SN) echogenicity in drug-induced parkinsonism (DIP), Parkinson's disease (PD), and healthy controls. A subgroup analysis of DIP by clinical…
  • 2017 International Congress

    Estimation of Tardive Dyskinesia Incidence and Prevalence in the United States

    A. Dhir, T. Schilling, V. Abler, R. Potluri, B. Carroll (New York, NY, USA)

    Objective: To estimate the current and expected epidemiology of tardive dyskinesia (TD) in the United States (US), stratified by level of severity. Background: TD is…
  • 2017 International Congress

    Parkinson’s disease and comorbidity: A US national perspective

    A. Mithal, B. Lingala, A. Niyazov, A. Guo, C. Marras, G. Singh (Woodside, CA, USA)

    Objective: To study comorbidities in Parkinson’s disease (PD) in the US. Background: PD is a chronic multisystem progressive neurodegenerative disease. Understanding patient comorbidities is important…
  • 2017 International Congress

    Variations in ANO3 gene in patients with cervical dystonia

    V. Han, V. Habalova, L. Klimcakova, J. Zidzik, M. Skorvanek, Z. Gdovinova (Kosice, Slovakia)

    Objective: The aim of our study was to establish prevalence of variants in the gene for anoctamin 3 (ANO3) in a population of patients with…
  • 2017 International Congress

    Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.

    N. Rocha, E. Furr-Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To evaluate predictors for psychosis in HD. Background: Behavioral problems are present across all stages of HD, even preceding the development of the motor…
  • 2017 International Congress

    Gait Analysis in Patients with Huntington’s Disease

    Y.-M. Park, S. Pyo, H.-M. Lee, M.-J. Kim, S.-B. Koh (Seoul, Republic of Korea)

    Objective: The aim of this study is to investigate the temporospatial gait parameters in patients with HD in comparison with healthy control. Background: Gait disturbance…
  • 2017 International Congress

    Factors Influencing Completion of Predictive Testing for Huntington’s Disease (HD)

    M. Patel, V. Sung (Birmingham, AL, USA)

    Objective: To determine if the new simplified testing protocol led to an increase in completion rate of predictive testing for HD, and to study some…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley